Background and aims With the aim of increasing our knowledge on the mutual interplay between miRNAs and lipids, which is still limited, a novel approach integrating miRNomic and lipidomic data gathered from mice with specific lipid traits was explored. Methods miRNomic and lipidomic analyses were previously performed in wild-type, Pcsk9 and Ldlr knockout mice fed normal laboratory diet or Western diet. miRNAs were high-throughput sequenced in liver, aorta, white adipose tissue, duodenum, jejunum, ileum and brain, whereas lipids were quantified by high-throughput mass-spectrometry in liver, aorta and plasma. miRNA expression levels were tested for correlation with each lipid measurement in different samples, and correlations were selected based on strict stringency criteria. In vitro experiments with miRNA mimics or inhibitors in mouse hepatoma cells were performed to validate correlations. Results Correlation analyses between miRNA expression levels and lipid concentrations in the different experimental conditions led to the selection of miRNAs potentially playing a major role in the regulation of lipid levels. Correlations mainly clustered in liver. Among selected miRNAs, some were already known to be related to lipid metabolism (miR-33, miR-210 and miR-21a) whereas others, including miR-431–5p, miR-434–3p, miR-434–5p and miR-677–5p had never been associated to lipidome perturbations before. In vitro experiments allowed to highlight a possible role of miR-431–5p andmiR-677–5p in the modulation of cholesterol and triglyceride concentrations. Conclusions This study bridged miRNomic and lipidomic data in relevant mouse models, allowing to highlight novel miRNAs potentially playing a role in the modulation of lipid levels.

Integrated high-throughput miRNomics and lipidomics in mice with altered lipoprotein metabolism / S. Manzini, A. Colombo, E. Franchi, G. Poletti, M. Busnelli, G. Chiesa. - In: ATHEROSCLEROSIS. - ISSN 1879-1484. - 413:(2026 Feb), pp. 120622.1-120622.11. [10.1016/j.atherosclerosis.2025.120622]

Integrated high-throughput miRNomics and lipidomics in mice with altered lipoprotein metabolism

S. Manzini
Co-primo
;
A. Colombo
Co-primo
;
E. Franchi;M. Busnelli
Co-ultimo
;
G. Chiesa
Co-ultimo
2026

Abstract

Background and aims With the aim of increasing our knowledge on the mutual interplay between miRNAs and lipids, which is still limited, a novel approach integrating miRNomic and lipidomic data gathered from mice with specific lipid traits was explored. Methods miRNomic and lipidomic analyses were previously performed in wild-type, Pcsk9 and Ldlr knockout mice fed normal laboratory diet or Western diet. miRNAs were high-throughput sequenced in liver, aorta, white adipose tissue, duodenum, jejunum, ileum and brain, whereas lipids were quantified by high-throughput mass-spectrometry in liver, aorta and plasma. miRNA expression levels were tested for correlation with each lipid measurement in different samples, and correlations were selected based on strict stringency criteria. In vitro experiments with miRNA mimics or inhibitors in mouse hepatoma cells were performed to validate correlations. Results Correlation analyses between miRNA expression levels and lipid concentrations in the different experimental conditions led to the selection of miRNAs potentially playing a major role in the regulation of lipid levels. Correlations mainly clustered in liver. Among selected miRNAs, some were already known to be related to lipid metabolism (miR-33, miR-210 and miR-21a) whereas others, including miR-431–5p, miR-434–3p, miR-434–5p and miR-677–5p had never been associated to lipidome perturbations before. In vitro experiments allowed to highlight a possible role of miR-431–5p andmiR-677–5p in the modulation of cholesterol and triglyceride concentrations. Conclusions This study bridged miRNomic and lipidomic data in relevant mouse models, allowing to highlight novel miRNAs potentially playing a role in the modulation of lipid levels.
Cholesterol; Lipidomics; Liver; Mouse models; Small RNA seq
Settore BIOS-11/A - Farmacologia
Settore BIOS-12/A - Anatomia umana
feb-2026
dic-2025
Article (author)
File in questo prodotto:
File Dimensione Formato  
ATH 2026.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Licenza: Nessuna licenza
Dimensione 10.06 MB
Formato Adobe PDF
10.06 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1235556
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex 0
social impact